未登录

F

Filippo Rossignoli

Harvard Medical School

H指数:13

被引数:821

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A nanobody-stem cell platform targeting innate and adaptive immune axis in the tumour microenvironment

IF10.8

2026-01-170

OAAI

Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticles

通过IL-10-mRNA纳米颗粒对肿瘤免疫进行系统性重编程

Nature Nanotechnology

IF34.9

2025-08-110

PRE

Allogeneic stem cells engineered to release interferon ,B and scFv-PD1 target glioblastoma and alter the tumor microenvironment

IF3.2

2024-10-011

PRE

Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice (vol 14, 1324618, 2024)

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-08-050

OAAI

Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-01-116

OAAI

Developing and characterizing a two-layered safety switch for cell therapies

CANCER BIOLOGY & THERAPY

IF4.6

2023-07-134

OAAI

An off-the-shelf Twin BiTE combination therapy controls heterogenous glioblastoma and shapes immune response

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2023-01-0430

OA

NK cells in the brain: implications for brain tumor development and therapy

Trends in Molecular Medicine

IF13.8

2022-03-0117

OAAI

Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm

IF3.6

2021-03-0745

OA

Challenging pancreatic ductal adenocarcinoma and its stroma by a combination of chemo and gene therapy: A preclinical study

CANCER RESEARCH

IF16.6

2019-12-130

PRE

Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer

SCIENTIFIC REPORTS

IF3.9

2019-02-1158

OAAI

MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma

IF13.3

2019-01-0142

OAAI

Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors

CANCER GENE THERAPY

IF5

2018-11-2276

OAAI

Human Herpes simplex 1 virus infection of endometrial decidual tissue-derived MSC alters HLA-G expression and immunosuppressive functions

HUMAN IMMUNOLOGY

IF2.2

2018-11-019

PREAI

Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy

CANCER GENE THERAPY

IF5

2018-06-2945

OAAI

SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA

IF3.2

2016-06-012

PREAI

Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies

IF8.3

2015-08-12113

OAAI

Mesenchymal Progenitors Expressing TRAIL Induce Apoptosis in Sarcomas

IF3.6

2015-02-1749

OAAI